Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
Clinical trial NCT03208933 · COMPLETED
Trial details
- NCT number
- NCT03208933
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2019-11-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.